Intracellular sodium sensing: SIK1 network, hormone action and high blood pressure

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 12, 2010, Pages 1140-1149

  Jaitovich, Ariel ^a,b   Bertorello, Alejandro M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Division of Medical Toxicology   (United States)

Author keywords

Adducin; Aldosterone; Angiotensin II; Dopamine; Gene regulation; High blood pressure; K+ ATPase; Na+; Salt inducible kinase

Indexed keywords

ADDUCIN; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; DOPAMINE; INSULIN; PHOSPHOTRANSFERASE; SALT INDUCIBLE KINASE 1; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ARTERIAL PRESSURE; CALCIUM SIGNALING; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CYTOSOL; ENZYME ACTIVATION; EXPERIMENTAL MODEL; GENE CONTROL; GENE MUTATION; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HYPERTENSION; KIDNEY EPITHELIUM; METABOLIC SYNDROME X; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; REVIEW; SODIUM CELL LEVEL; SODIUM TRANSPORT;

ANIMALS; BLOOD PRESSURE; CALCIUM SIGNALING; CYTOSOL; HUMANS; INSULIN; KIDNEY; METABOLIC SYNDROME X; MICE; MUTATION; PROTEIN-SERINE-THREONINE KINASES; SODIUM; SODIUM-POTASSIUM-EXCHANGING ATPASE;

ANIMALIA; MAMMALIA;

EID: 78049299533     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.03.009     Document Type: Review

References (113)

1. Gyuton A.C., Hall J.E. Textbook of Medical Physiology 2005, Saunders Co.
2. Kasper D.L., Braunwald E., Hauser S., et al. Harrison's Principles of Internal Medicine 2008, 17e. McGraw Hill Professional.
3. Ernst M., Moser M. Use of diuretics in patients with hypertension. N. Engl. J. Med. 2009, 361:2153-2164.
4. Jessup M., Brozena S. Heart failure. N. Engl. J. Med. 2003, 348:2007-2018.
5. Gines P., Cardenas A., Arroyo V., Rodes J. Management of cirrhosis and ascites. N. Engl. J. Med. 2004, 350:1646-1654.
6. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
7. Qureshi A.I., Suarez J.I. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit. Care Med. 2000, 28:3301-3313.
8. Ware L.B., Matthay M.A., Acute The Respiratory distress syndrome. N. Engl. J. Med. 2000, 342:1334-1349.
9. Sznajder J.I., Factor P., Ingbar D.H. Lung edema clearance: role of Na(+)-K(+)-ATPase. J. Appl. Physiol. 2002, 93:1860-1866.
10. Sznajder J.I. Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive. Am. J. Respir. Crit. Care Med. 2001, 163:1293-1294.
11. Humphrey H., Hall J., Sznajder I., Silverstein M., Wood L. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990, 97:1776-1780.
12. Sznajder J.I., Wood L.D. Beneficial effects of reducing pulmonary edema in patients with acute hypoxemic respiratory failure. Chest 1991, 100:890-892.
13. Adir Y., Welch L.C., Dumasius V., Factor P., Sznajder J.I., Ridge K.M. Overexpression of the Na-K-ATPase alpha2-subunit improves lung liquid clearance during ventilation-induced lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2008, 294:L1233-1237.
14. Jaitovich A., Sznajder J.I. Improving survival by increasing lung edema clearance: is airspace delivery of dopamine a solution?. Crit. Care 2008, 12:135.
15. Awad S., Allison S.P., Lobo D.N. The history of 0.9% saline. Clin. Nutr. 2008, 27:179-188.
16. Bohnert H.J., Nelson D.E., Jensen R.G. Adaptations to environmental stresses. Plant Cell. 1995, 7:1099-1111.
17. Stein W.D. The sodium pump in the evolution of animal cells. Philos Trans R Soc Lond B Biol Sci. 1995, 349:263-269.
18. Jaitovich A., Bertorello A.M. Semin. Nephrol. 2006, 26:386-392.
19. Therien A.G., Blostein R. Mechanisms of sodium pump regulation. Am. J. Physiol. Cell Physiol. 2000, 279:C541-C566.
20. Kaplan J.H. A moving new role for the sodium pump in epithelial cells and carcinomas. Sci. STKE 2005, 289:pe31.
21. Kuhlbrandt W. Biology structure and mechanism of P-type ATPases. Nat. Rev. Mol. Cell Biol. 2004, 5:282-295.
22. Stein W.D. Cell volume homeostasis: ionic and nonionic mechanisms. The sodium pump in the emergence of animal cells. Int. Rev. Cytol. 2002, 215:231-258.
23. Alberts B., et al. Molecular biology of the cell 2002, Garland Science, New York. 4th ed.
24. Boron W.F. Regulation of intracellular pH. Adv. Physiol. Educ. 2004, 28:160-179.
25. Fish E.M., Molitoris B.A. Alterations in epithelial polarity and the pathogenesis of disease states. N. Engl. J. Med. 1994, 330:1580-1588.
26. Burnay M.G., Crambert G., Kharoubi-Hess S., Geering K., Horisberger J.D. Electrogenicity of Na,K- and H,K-ATPase activity and presence of a positively charged amino acid in the fifth transmembrane segment. J Biol Chem. 2003, 278:19237-19244.
27. Axelsen K.B., Palmgren M.G. Evolution of substrate specificities in the P-type ATPase superfamily. J. Mol. Evol. 1998, 46:84-101.
28. Palmgren M.G., Axelsen K.B. Evolution of P-type ATPases. Biochim. Biophys. Acta 1998, 1365:37-45.
29. +-ATPase alpha subunit and regulates its trafficking. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6556-6561.
30. Doné S.C., Leibiger I.B., Efendiev R., Katz A.I., Leibiger B., Berggren P.O., Pedemonte C.H., Bertorello A.M. Tyrosine 537 within the Na+, K+-ATPase alpha-subunit is essential for AP-2 binding and clathrin-dependent endocytosis. J. Biol. Chem. 2002, 277:17108-17111.
31. Efendiev R., Yudowski G.A., Zwiller J., Leibiger B., Katz A.I., Berggren P.O., Pedemonte C.H., Leibiger I.B., Bertorello A.M. Relevance of dopamine signals anchoring dynamin-2 to the plasma membrane during Na+, K+-ATPase endocytosis. J. Biol. Chem. 2002, 277:44108-44114.
32. Zatti A., Chauvet V., Rajendran V., Kimura T., Pagel P., Caplan M.J. The C-terminal tail of the polycystin-1 protein interacts with the Na, K-ATPase alpha-subunit. Mol. Biol. Cell. 2005, 16:5087-5093.
33. Li Z., Xie Z. The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades. Pflugers Arch. 2009, 457:635-644.
34. Kimura T., Allen P.B., Nairn A.C., Caplan M.J. Arrestins and spinophilin competitively regulate Na+, K+-ATPase trafficking through association with a large cytoplasmic loop of the Na+, K+-ATPase. Mol. Biol. Cell. 2007, 18:4508-4518.
35. Efendiev R., Budu C.E., Bertorello A.M., Pedemonte C.H. G-protein-coupled receptor-mediated traffic of Na, K-ATPase to the plasma membrane requires the binding of adaptor protein 1 to a Tyr-255-based sequence in the alpha-subunit. J. Biol. Chem. 2008, 283:17561-17567.
36. Sjöström M., Stenström K., Eneling K., Zwiller J., Katz A.I., Takemori H., Bertorello A.M. SIK1 is part of a cell sodium-sensing network that regulates active sodium transport through a calcium-dependent process. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16922-16927.
37. Wang Z., Takemori H., Halder S.K., Nonaka Y., Okamoto M. Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet-treated rat adrenal. FEBS Lett. 1999, 453:135-139.
38. Carlson M., Osmond B.C., Botstein D. Mutants of yeast defective in sucrose utilization. Genetics 1981, 98:25-40.
39. Ruiz J.C., Conlon F.L., Robertson E.J. Identification of novel protein kinases expressed in the myocardium of the developing mouse heart. Mech. Development 1994, 48:153-164.
40. Stephenson A., Huang G.Y., Huang G.Y., Nguyen N.T., Reuter S., McBride J.L., Ruiz J.C. snf1lk encodes a protein kinase that may function in cell cycle regulation. Genomics 2004, 83:1105-1115.
41. Hardie D.G., Carling D., Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?. Annu. Rev. Biochem. 1998, 67:821-855.
42. Takemori H., Okamoto M. Regulation of CREB-mediated gene expression by salt inducible kinase. J. Ster. Biochem. Mol. Biol. 2008, 108:287-291.
43. Katoh Y., Takemori H., Doi J., Okamoto M. Identification of the nuclear localization domain of salt-inducible kinase. Endocr. Res. 2002, 28:315-318.
44. Horike N., Takemori H., Katoh Y., Doi J., Okamoto M. Roles of several domains identified in the primary structure of salt-inducible kinase (SIK). Endocr. Res. 2002, 28:291-294.
45. Jaleel M., McBride A., Lizcano J.M., Deak M., Toth R., Morrice N.A., Alessi D.R. Identification of the sucrose non-fermenting related kinase SNRK, as a novel LKB1 substrate. FEBS Lett. 2005, 579:1417-1423.
46. Hashimoto Y.K., Satoh T., Okamoto M., Takemori H. Importance of autophosphorylation at Ser186 in the A-loop of salt inducible kinase 1 for its sustained kinase activity. J. Cell Biochem. 2008, 104:1724-1733.
47. +-ATPase activity is modulated by intracellular sodium concentration. J Biol Chem. 2002, 277:11489-11496.
48. +-ATPase endocytosis. J. Biol. Chem. 1998, 273:8814-8819.
49. +-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and Is responsible for the decreased activity in epithelial cells. J. Biol. Chem. 1999, 274:1920-1927.
50. Lecuona E., Dada L.A., Sun H., Butti M.L., Zhou G., Chew T.L., Sznajder J.I. Na,K-ATPase alpha1-subunit dephosphorylation by protein phosphatase 2A is necessary for its recruitment to the plasma membrane. FASEB J. 2006, 20:2618-2620.
51. Longin S., Jordens J., Martens E., Stevens I., Janssens V., Rondelez E., De Baere I., Derua R., Waelkens E., Goris J., Van Hoof C. An inactive protein phosphatase 2A population is associated with methylesterase and can be re-activated by the phosphotyrosyl phosphatase activator. Biochem. J. 2004, 380:111-119.
52. Ogris E., Du X., Nelson K.C., Mak E.K., Yu X.X., Lane W.S., Pallas D.C. A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2A. J. Biol. Chem. 1999, 274:14382-14391.
53. Pawson T., Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 2003, 300:445-455.
54. Lemmers C., Medina E., Delgrossi M.H., Michel D., Arsanto J.P., Le Bivic A. hINADl/PATJ, a homolog of discs lost, interacts with crumbs and localizes to tight junctions in human epithelial cells. J. Biol. Chem. 2002, 277:25408-25415.
55. Chen Z., Leibiger I., Katz A.I., Bertorello A.M.A. Pals-associated tight junction protein functionally links dopamine and angiotensin II to the regulation of sodium transport in renal epithelial cells. Br. J. Pharmacol. 2009, 158:486-493.
56. Houslay M.D. Disrupting specific PDZ domain-mediated interactions for therapeutic benefit. Br. J. Pharmacol. 2009, 158:483-485.
57. Khundmiri S.J., Weinman E.J., Steplock D., Cole J., Ahmad A., Baumann P.D., Barati M., Rane M.J., Lederer E. Parathyroid hormone regulation of Na+, K+-ATPase requires the PDZ 1 domain of sodium hydrogen exchanger regulatory factor-1 in opossum kidney cells. J. Am. Soc. Nephrol. 2005, 16:2598-2607.
58. Knight K.K., Wentzlaff D.M., Snyder P.M. Intracellular sodium regulates proteolytic activation of the epithelial sodium channel. J. Biol. Chem. 2008, 283:27477-27482.
59. Bertorello A.M., Zhu J.K. SIK1/SOS2 networks: decoding sodium signals via calcium-responsive protein kinase pathways. Pflugers Arch. 2009, 458:613-619.
60. Liu J., Ishitani M., Halfter U., Kim C.-S., Zhu J.-K. The Arabidopsis thaliana SOS2 gene encodes a protein kinase that is required for salt tolerance. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3730-3734.
61. Liu J., Zhu J.-K. Zhu, A calcium sensor homolog required for plant salt tolerance, Science 1998, 280:1943-1945.
62. Halfter U., Ishitani M., Zhu J.-K. The Arabidopsis SOS2 protein kinase physically interacts with and is activated by the calcium-binding protein SOS3. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3735-3740.
63. Horike N., Takemori H., Katoh Y., Doi J., Min L., Asano T., Sun X.J., Yamamoto H., Kasayama S., Muraoka M., Nonaka Y., Okamoto M. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J. Biol. Chem. 2003, 278:18440-18447.
64. Du J., Chen Q., Takemori H., Xu H. SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes. Obesity 2008, 16:531-538.
65. Muraoka M., Fukushima A., Viengchareun S., Lombès M., Kishi F., Miyauchi A.A., Kanematsu M., Doi J., Kajimura J., Nakai R., Uebi T., Okamoto M., Takemori H. Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes. Am. J. Physiol. 2009, 296:E1430-E1439.
66. Katoh Y., Takemori H., Lin X.Z., Tamura M., Muraoka M., Satoh T., Tsuchiya Y., Min L., Doi J., Miyauchi A., Witters L.A., Nakamura H., Okamoto M. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J. 2006, 273:2730-2734.
67. Dentin R., Liu Y., Koo S.H., Hedrick S., Vargas T., Heredia J., Yates J., Montminy M. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 2007, 449:366-369.
68. Yoon Y.S., Seo W.Y., Lee M.W., Kim S.T., Koo S.H. Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation. J. Biol. Chem. 2009, 284:10446-10455.
69. Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G., Jeffries S., Guzman E., Niessen S., Yates J.R., Takemori H., Okamoto M., Montminy M. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 2004, 119:61-74.
70. Koo S.H., Flechner L., Qi L., Zhang X., Screaton R.A., Jeffries S., Hedrick S., Xu W., Boussouar F., Brindle P., Takemori H., Montminy M. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005, 437:1109-1111.
71. Lizcano J.M., Göransson O., Toth R., Deak M., Morrice N.A., Boudeau J., Hawley S.A., Udd L., Mäkelä T.P., Hardie D.G., Alessi D.R. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J. 2004, 23:833-843.
72. Cheng H., Liu P., Wang Z.C., Zou L., Santiago S., Garbitt V., Gjoerup O.V., Iglehart J.D., Miron A., Richardson A.L., Hahn W.C., Zhao J.J. SIK1 Couples LKB1 to p53-dependent anoikis and suppresses metastasis. Sci. Signal. 2009, 2:35.
73. +-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am. J. Physiol. 1988, 254:F795-F801.
74. Féraille E., Doucet A. Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control. Physiol. Rev. 2001, 81:345-418.
75. + transporter subcellular distribution, abundance, and phosphorylation status. Am. J. Physiol. 2008, 295:1003-1016.
76. Cinelli A.R., Efendiev R., Pedemonte C.H. Trafficking of Na-K-ATPase and dopamine receptor molecules induced by changes in intracellular sodium concentration of renal epithelial cells. Am. J. Physiol. 2008, 295:F1117-F1125.
77. Skou J.C. The Na, K-pump. Methods Enzymol. 1988, 156:1-25.
78. Alexander R.W., Gill G.R., Yamabe H., Lovenberg W., Keiser H.R. Effect of dietary sodium and acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J. Clin. Invest. 1974, 54:194-200.
79. Aperia A.C. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu. Rev. Physiol. 2000, 62:621-647.
80. + regulates dopamine and angiotensin II receptors availability at the plasma membrane and their cellular responses in renal epithelia. J. Biol. Chem. 2003, 278:28719-28722.
81. Soares-Da-Silva P., Serrão M.P., Pinho M.J., Bonifácio M.J. Cloning and gene silencing of LAT2, the L-3, 4-dihydroxyphenylalanine (l-DOPA) transporter, in pig renal LLC-PK1 epithelial cells. FASEB J. 2004, 18:1489-1498.
82. Brismar H., Asghar M., Carey R.M., Greengard P., Aperia A. Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:5573-5578.
83. Takemoto F., Cohen H.T., Satoh T., Katz A.I. Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron. Pflugers Arch. 1992, 421:302-306.
84. Mao L., Hartl D., Nolden T., Koppelstätter A., Klose J., Himmelbauer H., Zabel C. Pronounced alterations of cellular metabolism and structure due to hyper- or hypo-osmosis. J. Proteome Res. 2008, 7:3968-3983.
85. Willenberg H.S., Schinner S., Ansurudeen I. New mechanisms to control aldosterone synthesis. Horm. Metab. Res. 2008, 40:435-441.
86. Yanagibashi K., Haniu M., Shively J.E., Shen W.H., Hall P. The synthesis of aldosterone by the adrenal cortex. Two zones (fasciculata and glomerulosa) possess one enzyme for 11 beta-, 18-hydroxylation, and aldehyde synthesis. J. Biol. Chem. 1986, 261:3556-3562.
87. Okamoto M., Nonaka Y., Takemori H., Doi J. Molecular identity and gene expression of aldosterone synthase cytochrome P450. Biochem. Biophys. Res. Com. 2005, 338:325-330.
88. Bassett M.H., Suzuki T., Sasano H., White P.C., Rainey W.E. The orphan nuclear receptors Nurr1 and NGFIB regulate adrenal aldosterone production. Mol. Endocrinol. 2004, 18:279-290.
89. Doi J., Takemori H., Lin X., Horike N., Katoh Y., Okamoto M. Salt-inducible kinase represses cAMP-dependent protein kinase-mediated activation of human cholesterol side chain cleavage cytochrome P450 promoter through the CREB basic leucine zipper domain. J. Biol. Chem. 2002, 277:15629-15637.
90. Summa V., Mordasini D., Roger F., Bens M., Martin P.Y., Vandewalle A., Verrey F., Féraille E. Short term effect of aldosterone on Na, K-ATPase cell surface expression in kidney collecting duct cells. J. Biol. Chem. 2001, 276:47087-47093.
91. Rapp J.P. Genetic analysis of inherited hypertension in the rat. Physiol. Rev. 2000, 80:135-172.
92. Crowley S.D., Gurley S.B., Herrera M.J., Ruiz P., Griffiths R., Kumar A.P., Kim H.S., Smithies O., Lee T.H., Coffman T.M. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17985-17990.
93. Dostanic-Larson I., Van Huysse J.W., Lorenz J.N., Lingrel J.B. The highly conserved cardiac glycoside binding site of Na, K-ATPase plays a role in blood pressure regulation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15845-15850.
94. Makhanova N., Sequeira-Lopez M.L., Gomez R.A., Kim H.S., Smithies O. Disturbed homeostasis in sodium-restricted mice heterozygous and homozygous for aldosterone synthase gene disruption. Hypertension 2006, 48:1151-1159.
95. Cusi D., Barlassina C., Azzani T., Casari G., Citterio L., Devoto M., Glorioso N., Lanzani C., Manunta P., Righetti M., Rivera R., Stella P., Troffa C., Zagato L., Bianchi G. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997, 349:1353-1357.
96. 2+ exchanger type-1 in vascular smooth muscle. Nat. Med. 2004, 10:1193-1199.
97. Meneton P., Jeune X., de Wardener H.E., MacGregor G.A. Links between dietary salt intake, renal salt handling, blood presure, and cardiovascular diseases. Physiol. Rev. 2005, 85:679-715.
98. Melander O., von Wowern F., Frandsen E., Burri P., Willsteen G., Aurell M., Hulthén U.L. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma. J. Hypertens. 2007, 25:619-627.
99. A. Jaitovich, A.M. Bertorello, Salt, Na+, K+-ATPase and hypertension, Life Sci. Life Sci. 86 (2010) 73-78.
100. Tripodi G., Valtorta F., Torielli L., Chieregatti E., Salardi S., Trusolino L., Menegon A., Ferrari P., Marchisio P.C., Bianchi G. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J. Clin. Invest. 1996, 97:2815-2822.
101. Stenström K., Takemori H., Bianchi G., Katz A.I., Bertorello A.M. Blocking the salt-inducible kinase 1 network prevents the increases in cell sodium transport caused by a hypertension-linked mutation in human alpha-adducin. J. Hypertens 2009, 27:2452-2457.
102. +-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ. Res. 2004, 95:1100-1108.
103. Torielli L., Tivodar S., Montella R.C., Iacone R., Padoani G., Tarsini P., Russo O., Sarnataro D., Strazzullo P., Ferrari P., Bianchi G., Zurzolo C. alpha-Adducin mutations increase Na/K pump activity in renal cells by affecting constitutive endocytosis: implications for tubular Na reabsorption. Am. J. Physiol. 2008, 295:478-487.
104. Ferrari P., Ferrandi M., Tripodi G., Torielli L., Padoani G., Minotti E., Melloni P., Bianchi G. PST 2238: a new antihypertensive compound that modulates Na, K-ATPase in genetic hypertension. J. Pharm. Eexp. Ther. 1999, 288:1074-1083.
105. Liu J., Kesiry R., Periyasamy S.M., Malhotra D., Xie Z., Shapiro J.I. Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Intern. 2004, 66:227-241.
106. +-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 1993, 21:767-771.
107. Zhang Y., Yuan Z., Ge H., Ren Y. Effects of long-term ouabain treatment on blood pressure, sodium excretion, and renal dopamine D(1) receptor levels in rats. J. Comp. Physiol. 2009, 180:117-124.
108. Muscelli E., Natali A., Bianchi S., Bigazzi R., Galvan A.Q., Sironi A.M., Frascerra S., Ciociaro D., Ferrannini E. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am. J. Hypertens. 1996, 9:746-752.
109. Brands M.W., Bell T.D., Rodriquez N.A., Polavarapu P., Panteleyev D. Chronic glucose infusion causes sustained increases in tubular sodium reabsorption and renal blood flow in dogs. Am. J. Physiol. 2009, 296:R265-R271.
110. Feraille E., Marsy S., Cheval L., Barlet-Bas C., Khadouri C., Favre H., Doucet A. Sites of antinatriuretic action of insulin along rat nephron. Am. J. Physiol. 1992, 263:175-179.
111. Ji W., Foo J.N., O'Roak B.J., Zhao H., Larson M.G., Simon D.B., Newton-Cheh C., State M.W., Levy D., Lifton R.P. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat. Genet. 2008, 40:592-599.
112. C. Newton-Cheh, T. Johnson, V. Gateva, M.D. Tobin, M. Bochud, L. Coin, S.S. Najjar, J.H. Zhao, S.C. Heath, S. Eyheramendy, K. Papadakis, B.F. Voight, L.J. Scott, F. Zhang, M. Farrall, T. Tanaka, C. Wallace, J.C. Chambers, K.T. Khaw, P. Nilsson, P. van der Harst, S. Polidoro, D.E. Grobbee, N.C. Onland-Moret, M.L. Bots, L.V. Wain, K.S. Elliott, A. Teumer, J. Luan, G. Lucas, J. Kuusisto, P.R. Burton, D. Hadley, W.L. McArdle, Wellcome Trust Case Control Consortium, Brown M., Dominiczak A., Newhouse SJ., Samani N.J., Webster J., Zeggini E., Beckmann J.S., Bergmann S., Lim N., Song K., Vollenweider P., Waeber G., Waterworth D.M., Yuan X., Groop L., Orho-Melander M., Allione A., Di Gregorio A., Guarrera S., Panico S., Ricceri F., Romanazzi V., Sacerdote C., Vineis P., Barroso I., Sandhu M.S., Luben R.N., Crawford G.J., Jousilahti P., Perola M., Boehnke M., Bonnycastle L.L., Collins FS., Jackson A.U., Mohlke K.L., Stringham H.M., Valle T.T., Willer C.J., Bergman R.N., Morken M.A., Döring A., Gieger C., Illig T., Meitinger T., Org E., Pfeufer A., Wichmann H.E., Kathiresan S., Marrugat J., O'Donnell C.J., Schwartz S.M., Siscovick D.S., Subirana I., Freimer N.B., Hartikainen A.L., McCarthy M.I., O'Reilly P.F., Peltonen L., Pouta A., de Jong P.E., Snieder H., van Gilst W.H., Clarke R., Goel A., Hamsten A., Peden J.F., Seedorf U., Syvänen A.C., Tognoni G., Lakatta E.G., Sanna S., Scheet P., Schlessinger D., Scuteri A., Dörr M., Ernst F., Felix S.B., Homuth G., Lorbeer R., Reffelmann T., Rettig R., Völker U., Galan P., Gut I.G., Hercberg S., Lathrop G.M., Zelenika D., Deloukas P., Soranzo N., Williams F.M., Zhai G., Salomaa V., Laakso M., Elosua R., Forouhi N.G., Völzke H., Uiterwaal C.S., van der Schouw Y.T., Numans M.E., Matullo G., Navis G., Berglund G., Bingham S.A., Kooner J.S., Connell J.M., Bandinelli S., Ferrucci L., Watkins H., Spector T.D., Tuomilehto J., Altshuler D., Strachan D.P., Laan M., Meneton P., Wareham N.J., Uda M., Jarvelin M.R., Mooser V., Melander O., Loos R.J., Elliott P., Abecasis G.R., Caulfield M., Munroe P.B. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. PMID: 19430483.
113. Wang Y., O'Connell J.R., McArdle P.F., Wade J.B., Dorff S.E., Shah S.J., Shi X., Pan L., Rampersaud E., Shen H., Kim J.D., Subramanya A.R., Steinle N.I., Parsa A., Ober C.C., Welling P.A., Chakravarti A., Weder A.B., Cooper R.S., Mitchell B.D., Shuldiner A.R., Chang Y.-P.C. Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:226-231.